Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
7 search results for:

Kevin Fernando 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. play
    08-29-2021 | ESC 2021 | Conference coverage | Video

    EMPEROR-Preserved: The implications for primary care

    Kevin Fernando discusses the EMPEROR-Preserved findings and their likely impact on the treatment of people with heart failure with preserved ejection fraction, with or without diabetes, in primary care.

  2. 01-30-2019 | Cardiovascular outcomes | Case study | Article

    Cardiovascular risk reduction in type 2 diabetes

    Pharmacological management of comorbid cardiovascular risk and type 2 diabetes is undergoing a paradigm shift. General practitioner Kevin Fernando puts recommendations from the ADA/EASD into practice in this patient case study.

    Author:
    Kevin Fernando
  3. 04-17-2019 | Nephropathy | Podcast | Article

    Primary care expert commentary: The CREDENCE trial

    General practitioner Kevin Fernando talks to medwireNews about the importance of the CREDENCE trial from a primary care perspective (4:43).

  4. 08-27-2021 | ESC 2021 | News | Article

    EMPEROR-Preserved: A win for empagliflozin in HFpEF

    Kevin Fernando discusses the EMPEROR-Preserved findings and their likely impact on the treatment of people with heart failure with preserved ejection fraction, with or without diabetes, in primary care.

    Author:
    Eleanor McDermid
    Published in:
    N Engl J Med 2021; doi:10.1056/NEJMoa2107038 N Engl J Med 2021; doi:10.1056/NEJMc2112411 N Engl J Med 2021; doi:10.1056/NEJMe2113008
  5. 04-19-2018 | Older adults | News | Article

    Glycemic variability modifies mortality risk in older diabetes patients

    Speaking to medwireNews about the findings, Kevin Fernando, a general practitioner from North Berwick Health Centre, UK, noted that the adverse effect of falling HbA1c levels is “something unique to this older, more frail population.”

    Published in:
    Lancet Diabetes Endocrinol 2018; Advance online publication
  6. 05-06-2019 | SGLT2 inhibitors | News | Article

    Postmarketing data support Fournier gangrene link with SGLT2 inhibitors

    . © 2019 Springer Healthcare part of the Springer Nature group Ann Intern Med 2019; doi:10.7326/M19-0085 More on this topic In-depth article  | Kevin Fernando discusses Fournier gangrene and SGLT2 inhibitor use in primary care Quick guide  |  Real-world studies of SGLT2 inhibition and amputation risk Quick guide  |  Round-up of the SGLT2 inhibitor CV outcome trials

    Published in:
    Ann Intern Med 2019; doi:10.7326/M19-0085
  7. 04-15-2019 | Nephropathy | News | Article

    Canagliflozin may offer renal protection in people with type 2 diabetes and CKD

    Kevin Fernando talks about the CREDENCE findings from a primary care perspective.

    Published in:
    N Engl J Med 2019; doi:10.1056/NEJMoa1811744 N Engl J Med 2019; doi:10.1056/NEJMe1904740
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.